New UK cancer registry set up
This article was originally published in Clinica
Executive Summary
A new cancer registry is being created in the UK as part of a study into genetic predisposition to the disease, based at London's Royal Marsden Hospital. The announcement of the initiative comes at a time of heated debate surrounding the UK's data protection policy. Concern at the potentially detrimental effect it could have on research, particularly involving human tissue, has led to calls for a relaxation of recent guidelines concerning informed consent.